（1） Wang Binglin; Wang Yi; Sun Xiaofan; Deng Guoliang; Huang Wei; Wu Wei; Gu Yanhong; Tian Zhigang; Fan Zhimin; Xu Qiang; Chen Qiang; Sun Yang; CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell, Journal for ImmunoTherapy of Cancer, 2021, 9(8): 1-13
（2） Deng Guoliang#; Zhou Lisha#; Wang Binglin#; Sun Xiaofan; Zhang Qinchang; Chen Hongqi; Wan Ning; Ye Hui; Wu Xiaoqi; Sun Dongdong; Sun Yang; Cheng Haibo; Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation, Journal for ImmunoTherapy of Cancer, 2022, 1(10): e004874
（3） Huang Muyang#; Jiang Xiaoming#; Wang Binglin; Sun Yang; Lu Jinjian; Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms, Pharmacology &Therapeutics, 2021, 219: 107694
